Abstract:Objective: To study the alteration of cyclins and cyclin-dependent kinases (CDKs) activity in Fas-mediated cell cycle-specific apoptosis and its possible regulation mechanism. Methods: The leukemia Molt-4 cell line was used as target cells to establish the Fas-mediated cell cycle-specific apoptosis model. The cyclins expressions were detected using cyclin/DNA bi-parameter flow cytometry and validated using Western blotting. Apoptosis was detected using annexin V/propidium iodide (PI) and modified annexin V/PI (API) methods and analyzed using flow cytometry. The phosphorylation level of CDK1 at the site of Thr161 and that of CDK2 at Thr160 were determined using Western blotting. Results: Recombinant human Fas ligand (rhFasL) induced cells were arrested in G 1 phase. The expression of cyclin D3 markedly increased while cyclin E expression and phosphorylation level of CDK2 at Thr 160 decreased evidently before apoptosis. After apoptosis was induced, the expression of cyclin D3 decreased while the expression of cyclin E increased. Meanwhile, the expressions of cyclins A and B1 were unaltered. The phosphorylation level of CDK2 at the site of Thr160 had a significant decrease but that of CDK1 at the site of Thr161 and Tyr15 had only a little decrease. Roscovitine (5 μmol/L) promoted Fas-mediated apoptosis by down-regulating the phosphorylation level of CDK2 at the site of Thr160 and that of CDK1 at the site of Thr161. Conclusion: Fas-mediated apoptosis was cell cycle specific and initiated at late G 1 phase, which was the results of down-regulation of cyclin E/CDK2 activity and surveillance at the checkpoint of late G 1 phase. Cyclin D3/CDK complex might be the key factor for the induction of apoptosis.

Establishment of A Cell Model Based on Fkbp12 Dimerization for Screening of Fk506-Like Small Molecular Compounds

Establishment of A Cell Model Based on Fkbp12 Dimerization for Screening of Fk506-Like Neurotrophic Small Molecular Compounds

[Establishment of a Cell Model Targeted to NFAT Signal Transduction Pathway for Preliminary Screening of FK506-like Immunosuppressants].

Study on Proliferation Inhibiting and Apoptosis Inducing Effects of Cerulenin on Multiple Myeloma Cells

A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-xLInhibitors

Theoretical analysis of fas ligand-induced apoptosis with an ordinary differential equation model

Crystallization and Preliminary X-ray Crystallographic Studies of Human FAIM Protein.

High yield purification of an Isoleucine zipper modified CD95 Ligand with either biotin or DNA-oligomer binding domain for efficient Cell Apoptosis Induction

Synthesis, Biological Evaluation and Molecular Docking Studies of Novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone Derivatives

Structure Determination of Human Fas Apoptosis Inhibitory Molecule and Identification of the Critical Residues Linking the Interdomain Interaction to the Anti-Apoptotic Activity.

Three-dimensional Structure of Human FKBP52

Cyclin/CDK complex alteration and regulation mechanism in Fas-mediated tumor cell apoptosis in vitro

Screening of Small-Molecule Inhibitors of Protein-Protein Interaction with Capillary Electrophoresis Frontal Analysis.

Use a Phage Display Library to Identify Oligopeptides Binding to the Fas

A Mathematical Model of Fas Signaling Induced Apoptosis

Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free energy calculations

Selection and Identification of an ssDNA Aptamer for Fibroblast Activation Protein

Establishment of the Cell Model Used for Epidermal Growth Factor Effect Evaluation

Crystallization and preliminary crystallographic studies of the C-terminal domain of human FKBP52.

Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs

Discovery of 2,4-Diarylaminopyrimidine Derivatives Bearing Sulfonamide Moiety As Novel FAK Inhibitors